A European survey relating to cancer therapy and neutropenic infections: Nurse and patient viewpoints.

Hdl Handle:
http://hdl.handle.net/10147/234911
Title:
A European survey relating to cancer therapy and neutropenic infections: Nurse and patient viewpoints.
Authors:
Leonard, Kay
Affiliation:
Saint Luke's Radiation Oncology Centre, St James's Hospital, St James's Street, Dublin 8, Ireland.
Citation:
A European survey relating to cancer therapy and neutropenic infections: Nurse and patient viewpoints. 2011:notEur J Oncol Nurs
Journal:
European journal of oncology nursing : the official journal of European Oncology Nursing Society
Issue Date:
25-Sep-2011
URI:
http://hdl.handle.net/10147/234911
DOI:
10.1016/j.ejon.2011.08.004
PubMed ID:
21945189
Abstract:
PURPOSE: Severe neutropenia and febrile neutropenia (FN) are the major causes of morbidity, treatment interruptions and dose reductions in patients undergoing chemotherapy. The European Oncology Nursing Society (EONS) conducted an European survey to evaluate nurse perspectives on prevention of infection and FN in this setting, and how much they educate their patients about this. A separate survey explored these issues in patients receiving chemotherapy. METHODS: 217 nurse participants were identified by EONS from the membership database and 473 cancer patients who were receiving/had received chemotherapy were identified through patient advocacy groups. Questionnaires were completed anonymously online for both surveys. RESULTS: More than 90% of the nurses agreed that preventing infections including FN is extremely/very important for a successful chemotherapy outcome and said that they, or other health professionals in their practice, advised patients about these issues. Most (90%) indicated that they favoured giving treatment to protect against FN and infections in chemotherapy patients at risk, rather than treating infection after it develops, but 82% expressed concern over patient concordance with measures employed. A substantial proportion of patients reported emergency room visits, hospitalization and/or chemotherapy delays or changes as a result of neutropenia, infection or FN. However, only 44% said that their infection risk was discussed with them before starting chemotherapy. CONCLUSIONS: Our findings indicate that nurses recognise the importance of reducing the risk of infection and FN in patients undergoing chemotherapy, as well as the need to educate patients. However, results of the patient survey suggest a need for better patient education.
Item Type:
Article
ISSN:
1532-2122

Full metadata record

DC FieldValue Language
dc.contributor.authorLeonard, Kayen_GB
dc.date.accessioned2012-07-20T14:19:57Z-
dc.date.available2012-07-20T14:19:57Z-
dc.date.issued2011-09-25-
dc.identifier.citationA European survey relating to cancer therapy and neutropenic infections: Nurse and patient viewpoints. 2011:notEur J Oncol Nursen_GB
dc.identifier.issn1532-2122-
dc.identifier.pmid21945189-
dc.identifier.doi10.1016/j.ejon.2011.08.004-
dc.identifier.urihttp://hdl.handle.net/10147/234911-
dc.description.abstractPURPOSE: Severe neutropenia and febrile neutropenia (FN) are the major causes of morbidity, treatment interruptions and dose reductions in patients undergoing chemotherapy. The European Oncology Nursing Society (EONS) conducted an European survey to evaluate nurse perspectives on prevention of infection and FN in this setting, and how much they educate their patients about this. A separate survey explored these issues in patients receiving chemotherapy. METHODS: 217 nurse participants were identified by EONS from the membership database and 473 cancer patients who were receiving/had received chemotherapy were identified through patient advocacy groups. Questionnaires were completed anonymously online for both surveys. RESULTS: More than 90% of the nurses agreed that preventing infections including FN is extremely/very important for a successful chemotherapy outcome and said that they, or other health professionals in their practice, advised patients about these issues. Most (90%) indicated that they favoured giving treatment to protect against FN and infections in chemotherapy patients at risk, rather than treating infection after it develops, but 82% expressed concern over patient concordance with measures employed. A substantial proportion of patients reported emergency room visits, hospitalization and/or chemotherapy delays or changes as a result of neutropenia, infection or FN. However, only 44% said that their infection risk was discussed with them before starting chemotherapy. CONCLUSIONS: Our findings indicate that nurses recognise the importance of reducing the risk of infection and FN in patients undergoing chemotherapy, as well as the need to educate patients. However, results of the patient survey suggest a need for better patient education.en_GB
dc.languageENG-
dc.rightsArchived with thanks to European journal of oncology nursing : the official journal of European Oncology Nursing Societyen_GB
dc.titleA European survey relating to cancer therapy and neutropenic infections: Nurse and patient viewpoints.en_GB
dc.typeArticleen
dc.contributor.departmentSaint Luke's Radiation Oncology Centre, St James's Hospital, St James's Street, Dublin 8, Ireland.en_GB
dc.identifier.journalEuropean journal of oncology nursing : the official journal of European Oncology Nursing Societyen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.